UG Healthcare Corporation Limited (SGX:8K7)
Singapore · Delayed Price · Currency is SGD 0.0770
+0.0010 (1.32%)
At close: Sep 9, 2026
UG Healthcare Corporation Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 150.82 | 144.07 | 115.21 | 101.13 | 232.6 | |
Revenue Growth | 4.69% | 25.06% | 13.91% | -56.52% | -31.27% |
Cost of Revenue | 107.95 | 109.34 | 89.34 | 99.69 | 148.21 |
Gross Profit | 42.87 | 34.74 | 25.87 | 1.45 | 84.39 |
Selling, General & Admin | 37.31 | 35.55 | 32.49 | 26.57 | 33.22 |
Operating Expenses | 37.31 | 35.55 | 32.49 | 26.57 | 33.22 |
Operating Income | 5.56 | -0.82 | -6.63 | -25.12 | 51.17 |
Interest Expense | -2.54 | -2.19 | -1.28 | -0.92 | -0.81 |
Interest & Investment Income | 0.62 | 0.79 | 2.01 | 2.15 | 0.43 |
Earnings From Equity Investments | 0.03 | -0.04 | -0.08 | 0.56 | 0.1 |
Currency Exchange Gain (Loss) | - | -0.08 | -3.06 | 0.37 | - |
Other Non Operating Income (Expenses) | -1.15 | 0.36 | 2.04 | -0.08 | -2.15 |
EBT Excluding Unusual Items | 2.52 | -1.96 | -6.99 | -23.03 | 48.74 |
Impairment of Goodwill | - | -1 | - | - | - |
Gain (Loss) on Sale of Assets | 0.19 | - | - | - | 0.02 |
Asset Writedown | 1.3 | -0.78 | - | -5.33 | - |
Pretax Income | 4 | -3.74 | -6.99 | -28.36 | 48.76 |
Income Tax Expense | 1.35 | 0.98 | -0.31 | -1.4 | 8.96 |
Earnings From Continuing Operations | 2.65 | -4.72 | -6.68 | -26.96 | 39.8 |
Minority Interest in Earnings | -0.55 | 0.63 | 2.73 | 6.23 | -3 |
Net Income | 2.1 | -4.1 | -3.96 | -20.73 | 36.8 |
Net Income to Common | 2.1 | -4.1 | -3.96 | -20.73 | 36.8 |
Net Income Growth | - | - | - | - | -69.02% |
Shares Outstanding (Basic) | 624 | 624 | 624 | 624 | 620 |
Shares Outstanding (Diluted) | 624 | 624 | 624 | 624 | 620 |
Shares Change | - | - | - | 0.58% | 1.43% |
EPS (Basic) | 0.00 | -0.01 | -0.01 | -0.03 | 0.06 |
EPS (Diluted) | 0.00 | -0.01 | -0.01 | -0.03 | 0.06 |
EPS Growth | - | - | - | - | -69.45% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 14.35 | -6.05 | -11.1 | -44.7 | 33.21 |
Free Cash Flow Per Share | 0.02 | -0.01 | -0.02 | -0.07 | 0.05 |
Dividend Per Share | - | - | - | - | 0.003 |
Dividend Growth | - | - | - | - | -21.18% |
Gross Margin | 28.42% | 24.11% | 22.45% | 1.43% | 36.28% |
Operating Margin | 3.68% | -0.57% | -5.75% | -24.84% | 22.00% |
Profit Margin | 1.39% | -2.84% | -3.44% | -20.50% | 15.82% |
Free Cash Flow Margin | 9.51% | -4.20% | -9.63% | -44.20% | 14.28% |
EBITDA | 11.42 | 2.3 | -3.45 | -22.41 | 54.21 |
EBITDA Margin | 7.57% | 1.60% | -3.00% | -22.16% | 23.31% |
D&A For EBITDA | 5.86 | 3.12 | 3.18 | 2.71 | 3.05 |
EBIT | 5.56 | -0.82 | -6.63 | -25.12 | 51.17 |
EBIT Margin | 3.68% | -0.57% | -5.75% | -24.84% | 22.00% |
Effective Tax Rate | 33.80% | - | - | - | 18.38% |